Article
CaV3.3 Channelopathies.
Handbook of experimental pharmacology - 1 Jan 2023
El Ghaleb Yousra, Flucher Bernhard E
Abstract excerpt
CaV3.3 is the third member of the low-voltage-activated calcium channel family and the last to be recognized as disease gene. Previously, CACNA1I, the gene encoding CaV3.3, had been described as schizophrenia risk gene. More recently, de novo missense mutations in CACNA1I were identified in patients with variable degrees of neurodevelopmental disease with and without epilepsy. Their functional characterization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
